Immunotherapy Doctors Abroad — Page 3

The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).

Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.

Dr. Amir specializes in targeted therapy with Keytruda (Pembolizumab) for breast cancer, with over 30 presentations at scientific meetings.

• Recipient of multiple awards, including ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)
• Fellowship in Breast Cancer Research at Emory University
• Over 19 years of experience of experience in oncology

Chief Physician at BKZ Solingen's certified cancer center – Dr. Fox specializes in immunotherapy and molecular diagnostics for tumor diseases.

• 14 years of experience as a hematologist, oncologist, and immunologist
• Expert in molecular biology research for hemato-oncological diseases
• Member of German and American oncology societies
• Specializes in targeted therapies alongside immunotherapy

Univ. Prof. Dr. Wolfgang Köstler is a leading expert in breast cancer and gynecologic malignancies, with over 22 years of experience of experience in targeted cancer therapies at Wiener Privatklinik.

• Specializes in solid tumor oncology, focusing on breast and gynecologic cancers
• Deputy Head of the Clinical Division of Oncology at Medical University of Vienna
• Active in translational research and biomarker development for precision oncology
• Published extensively in leading international journals on tumor biology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Over a decade of experience in oncology
• Worked at Ankara Oncology Clinic and Erzurum Regional Training and Research Hospital
• Promoted to Associate Professor in 2016
• Studied medicine at Selcuk University

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Professor of Medical Oncology with over 29 years of experience of experience, specializing in advanced cancer treatments at İstinye University Liv Hospital Topkapı.

• Fellowship-trained in Medical Oncology at Trakya University
• Associate Professor and later Professor at Trakya University Faculty of Medicine
• Member of the Turkish Medical Oncology Association

Associate Professor of Medical Oncology at İstinye University Liv Hospital Topkapı – specializes in immunotherapy for cancer treatment.

• 15 years of experience of experience in medical oncology
• Member of the American Society of Clinical Oncology (ASCO)
• Published multiple peer-reviewed articles on cancer treatment outcomes
• Focuses on immunotherapy for various cancer types

Dr. Salman specializes in immunotherapy for various cancers, integrating targeted therapies and cancer vaccines. He trained at prestigious institutions like Memorial Sloan Kettering Cancer Center.

• Associate Professor at Katip Çelebi University with 32 years of experience in medical oncology
• Academic visitor at Moffitt Cancer Center in Florida, USA
• Board member of Turkish Society of Medical Oncology and European Society of Medical Oncology
• Uses comprehensive genomic profiling for personalized treatment plans
• Active in clinical research and experimental medical therapies

Dr. Alemdar specializes in medical oncology with extensive training at Akdeniz University – a leader in cancer research.

• Board-certified in medical oncology since 2018
• Practices at Medical Park Antalya Hospital Complex
• Over 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University – Turkey's premier cancer research center

Dr. Ozden specializes in medical oncology with over 27 years of experience of experience in internal medicine and oncology.

• Completed medical oncology subspecialty at Kocaeli University Faculty of Medicine
• Practiced internal medicine at multiple hospitals in Turkey
• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine

Dr. Elkhan Mammadov is a medical oncologist. He focuses on cancer diagnosis and treatment, including cytotoxic chemotherapy, hormone therapy, targeted therapy (smart drugs), and immunotherapy.

Education: Azerbaijan Medical University, MD (2004–2010). Istanbul University, Istanbul Faculty of Medicine, Internal Medicine training (2014–2019). Istanbul Medipol Mega University Hospital, Medical Oncology subspecialty training (2019–2022).

Experience: 5 years in Internal Medicine. 3 years in Medical Oncology.

Memberships: Turkish Society for Medical Oncology. ESMO (European Society for Medical Oncology). ASCO (American Society of Clinical Oncology).

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Lucía González Cortijo leads one of Spain's top oncology departments, specializing in immunotherapy for breast and gynecologic cancers.

• 20+ years focused exclusively on oncology
• Principal investigator in 20+ immunotherapy clinical trials
• Trained at MD Anderson Cancer Center Madrid
• Active member of ESMO and ASCO
• Leads La Vida en Rosa Foundation for women's cancer support

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Dr. Eytan Aharon Ben-Ami leads the Oncology Division at Sheba Medical Center in Israel. He specialized in sarcoma and bone oncology at the Dana-Farber Cancer Institute. Dr. Ben-Ami founded the Sheba Clinical Research Organization to advance cancer studies. He treats rare bone tumors and soft tissue sarcomas with personalized protocols.

• Heads the Early-Phase Clinical Trials Unit for innovative cancer therapies.
• Authored over 40 scientific publications on molecular mechanisms and early detection.
• Leads Phase I trials in targeted therapy and immunotherapy for rare cancers.
• Works at Sheba Medical Center, a top-10 hospital globally per Newsweek.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.